Related Experiment Videos
Post-transfusion purpura: case report.
R Kumar1, A Ghali, A W Ekaldious
1Al-Adan Hospital, Kuwait. docrk@hotmail.com
Annals of Hematology
|September 21, 2001
Summary
Post-transfusion purpura (PTP) is a rare bleeding disorder. This study presents two cases, highlighting variable treatment responses and the critical need for effective interventions in severe thrombocytopenia.
Area of Science:
- Hematology
- Immunology
- Transfusion Medicine
Background:
- Post-transfusion purpura (PTP) is a rare but severe bleeding disorder characterized by platelet alloimmunization.
- It typically manifests 5-10 days after blood transfusion in sensitized individuals, leading to profound thrombocytopenia and hemorrhage.
- While often self-resolving, PTP can cause life-threatening bleeding, necessitating prompt and effective management.
Observation:
- Two cases of PTP are presented in multiparous, PlA1-negative women who received their first blood transfusion.
- Both patients experienced severe thrombocytopenia and purpura following transfusion.
- Initial treatment with corticosteroids proved ineffective in both cases.
Findings:
- One patient responded to intravenous immunoglobulin (IVIG) therapy.
- Plasmapheresis was the definitive, life-saving treatment for the second patient.
- These findings underscore the variable efficacy of different treatment modalities for PTP.
Implications:
- The management of PTP requires a tailored approach, as no single treatment is universally effective.
- Prompt recognition and aggressive treatment are crucial to prevent potentially fatal hemorrhage.
- Further research into optimal PTP treatment strategies is warranted, especially for refractory cases.